2019
DOI: 10.1016/j.vaccine.2019.08.082
|View full text |Cite
|
Sign up to set email alerts
|

Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 69 publications
0
8
0
Order By: Relevance
“…M2e and LAH peptides are poorly immunogenic per se. Therefore, they have to be administered in association with adjuvant/delivery systems to induce robust immune responses in the host, including ligands of PRRs, bacterial toxins and derivatives, lipid-based particles, virus-like particles, organic and inorganic polymers and bacterial or viral vectored vaccines (5,(7)(8)(9)(10)(11)(12)(13)(14)(15). In this study, we have used innovative nanostructures developed in our research unit named "nanorings" as a mucosal vaccine delivery platform.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…M2e and LAH peptides are poorly immunogenic per se. Therefore, they have to be administered in association with adjuvant/delivery systems to induce robust immune responses in the host, including ligands of PRRs, bacterial toxins and derivatives, lipid-based particles, virus-like particles, organic and inorganic polymers and bacterial or viral vectored vaccines (5,(7)(8)(9)(10)(11)(12)(13)(14)(15). In this study, we have used innovative nanostructures developed in our research unit named "nanorings" as a mucosal vaccine delivery platform.…”
Section: Discussionmentioning
confidence: 99%
“…Owing to the high variability of IAV, an active area of research focuses on developing subunit vaccines containing conserved "universal" viral antigens, including epitopes located in the membrane proximal stalk domain of HA (HA2) and the ectodomain of the matrix protein 2 (M2e) (4,(6)(7)(8). Multiple vaccine candidates and platforms incorporating HA2 and/or M2e epitopes are under development, including fusion proteins with bacterial enterotoxins, flagellin, Neisseria meningititis outer membrane protein complex or Mycobacterium tuberculosis heat-shock protein 70, virus-like particles, bacterial outer membrane vesicles, bacteriophages, liposomes, immune stimulating complexes (ISCOM), bacterial or viral vectored vaccines, DNA or RNA vaccines, organic polymers such as chitosan, poly(lactic-co-glycolic acid) or poly-g-glutamic acid particles and inorganic nanoparticles such as gold nanoparticles (5,(7)(8)(9)(10)(11)(12)(13)(14)(15). These vaccine candidates were shown to provide protection against homologous and/or heterologous IAV challenges in pre-clinical trials.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Administration of analgesia drugs was unnecessary since the birds were euthanized soon after the emergence of clinical symptoms. Humane euthanasia was actualized by exposure to carbon dioxide (CO 2 ) as previously described ( Elaish et al, 2017 ; Elaish et al, 2019 ; Ghorbani et al, 2019 ; Jang et al, 2018 ). Three poults were placed in the euthanasia chamber connected to a CO 2 source, with CO 2 flow set at 10–30% displacement of chamber volume/minute.…”
Section: Methodsmentioning
confidence: 99%
“…Birds were observed for respiratory arrest and lack of heartbeat and the CO 2 flow was maintained for at least one minute after the respiratory arrest and lack of heartbeat were observed. Upon observation of death, an additional secondary physical euthanasia (cervical dislocation or removal of a vital organ) was performed before collection of tissues and carcass disposal ( Elaish et al, 2017 ; Elaish et al, 2019 ; Ghorbani et al, 2019 ; Jang et al, 2018 ).…”
Section: Methodsmentioning
confidence: 99%